...A来源的速效胰岛素制剂)用于4~18岁儿科糖尿病患者胰岛素泵的胰岛素皮下持续输注(continuous subcutaneous insulin infusion,CSII)。本品是首个获准作为这一用途的胰岛素类似物产品。
基于4个网页-相关网页
...的速效胰岛素制剂)用于4~18岁儿科糖尿病患者胰岛素泵的胰岛素皮下持续输注(continuous subcutaneous insulin infusion,CSII)。本品是首个获准作为这一用途的胰岛素类似物产品。
基于2个网页-相关网页
胰岛素皮下持续输注 continuous subcutaneous insulin infusion ; CSII
持续皮下输注 continuous subcutaneous insulin infusion ; CSII ; Continuous subcutaneous infusion
胰岛素泵持续皮下输注 continuous subcutaneous insulin infusion ; CSII
持续皮下输注法 continuous subcutaneous insulin injection ; CSII
素泵持续皮下输注法 CSII ; continuous subcutaneous insulin injection
持续皮下输注胰岛素 CSII
目的探讨持续皮下胰岛素输注在伴有糖尿病的腹部大手术后危重患者完全胃肠外营养期间的应用价值。
Objective to evaluate the value of the continuous subcutaneous insulin infusion in diabetic patients after abdominal major operation who were critical during the time of total parenteral nutrition.
目的比较胰岛素泵持续皮下胰岛素输注(CSII)法与传统小剂量胰岛素静滴法治疗糖尿病酮症酸中毒(dka)的短期疗效。
Objective to compare the short-term effects of continuous subcutaneous insulin infusion (CSII) and continuous venous insulin infusion in the treatment of diabetic ketoacidosis (DKA).
结论胰岛素泵持续皮下输注胰岛素治疗DKA较常规小剂量静脉滴注胰岛素更安全有效。
Conclusions The treatment of insulin pump was more effectively and safely than intravenous insulin infusion in patients with DKA.
应用推荐